A Win For Psyence Biomedical Ltd.
Thu, Dec 19, 2024 at 07:10 PM
Psyence Biomedical Ltd. (PBM:NASDAQ) soared at $2.46, representing a gain of 60.8%. On Thu, Dec 19, 2024, PBM:NASDAQ hit a New 2-Week High of $2.46. The stock got featured on our News Catalysts scanner on Tue, Dec 17, 2024 at 10:42 AM in the 'BIOTECH' category. From Fri, Dec 06, 2024, the stock recorded 11.11% Up Days and 40.00% Green Days
The stock spiked on Thu, Dec 19, 2024 at $7.87 with a volume of 75M+.
About Psyence Biomedical Ltd. (PBM:NASDAQ)
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.
Top 10 Gainers:
- PainReform Ltd. (PRFX:NASDAQ), 409.59%
- Nvni Group Limited (NVNI:NASDAQ), 317.19%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 122.72%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 92.42%
- Trio Petroleum Corp. (TPET:NYSEMKT), 79.16%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 64.56%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 60.78%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 56.25%
- Cara Therapeutics, Inc. (CARA:NASDAQ), 56.01%